Medical Device Network on MSN
FDA clears Francis Medical’s water vapour ablation treatment for prostate cancer
The Vanquish device’s clinical data demonstrated an elimination of MRI visible intermediate risk disease in 91% of patients ...
The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for ...
Canadian research suggests recommendations against screening for prostate cancer has led to a rise in the rates of stage 4 cases and less progress in mortality, even as other experts disagree and cite ...
The FDA has granted premarket approval (PMA) to the IsoPSA test, a novel, blood-based in vitro diagnostic kit designed to ...
Francis Medical, Inc., a privately-held medical device company developing the breakthrough Vanquish(R) Water Vapor Ablation System for the management of prostate cancer, today announced that the U.S.
Men diagnosed with prostate cancer have traditionally faced two choices: Do nothing and hope the tumor doesn’t grow between ...
PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA ...
Here is some news that, before too long, some of you may be able to use. There is a new technique for diagnosing prostate cancer. It is being deployed on an experimental basis at the National ...
The IsoPSA test is intended to help assess whether patients with elevated PSA levels should go on to receive a biopsy ...
Some of the less talked about topics for a number of Prostate cancer survivors are erectile dysfunction, low desire and a ...
King Charles III has been diagnosed with cancer, Buckingham Palace confirmed. In a statement, the palace said the diagnosis came after Charles underwent a prostate procedure. The palace did not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback